Your session is about to expire
← Back to Search
Propofol vs Sevoflurane for Anesthesia (ICHOR Trial)
ICHOR Trial Summary
This trial is testing whether there are differences in brain function between two types of anesthesia. Subjects will be randomly assigned to receive either propofol or sevoflurane, and the effects on brain function will be measured.
ICHOR Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowICHOR Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.ICHOR Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I am a patient under 1 year old.I have a condition that affects oxygen use or blood flow in my brain.I am at risk for propofol infusion syndrome due to existing health issues.I need anesthesia for my MRI scans.My baby was born before 25 weeks of pregnancy and is still under that age.I am at risk for a severe reaction to certain anesthesia due to a genetic condition.I can undergo an MRI scan.I am at risk of heart rhythm problems from certain anesthesia due to a genetic condition or medications I'm taking.I have no health issues that require the use of propofol or sevoflurane.I have a neuromuscular disease like Duchenne muscular dystrophy that causes high potassium levels.
- Group 1: Sevoflurane
- Group 2: Propofol
- Drug Has Already Been Approved - The FDA has already approved this drug, and is just seeking more data.
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Pivotal Trial - The final step before approval, pivotal trials feature drugs that have already shown basic safety & efficacy.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
What potential dangers are associated with the use of Randomized sevoflurane?
"There is an abundance of evidence suggesting Randomized sevoflurane's safety, so it earned a rating of 3."
How many participants are being enrolled in this research program?
"Affirmative. According to the clinicaltrials.gov database, this trial is actively recruiting participants and began on June 9th 2020. This study has been updated as recently as October 21st 2021 and requires 30 individuals at a single location."
Are there still vacancies for participants in this research study?
"Confirmed. According to the information located on clinicaltrials.gov, this medical study is currently enrolling patients. It first became available for public review June 9th 2020 and was last updated October 21st 2021 with a goal of recruiting 30 people from one location."
Share this study with friends
Copy Link
Messenger